Modification of cell mediated immune-response in patients treated with a polyvalent mechanical bacterial lysate

F. Braido, E. Traggiai, G. Lanzilli, G. Bazorro, C. Folli, V. Garelli, A. M. Riccio, G. Melioli (Genoa, Rome, Italy)

Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Session: Role of infection in exacerbations of COPD
Session type: Poster Discussion
Number: 3023
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Braido, E. Traggiai, G. Lanzilli, G. Bazorro, C. Folli, V. Garelli, A. M. Riccio, G. Melioli (Genoa, Rome, Italy). Modification of cell mediated immune-response in patients treated with a polyvalent mechanical bacterial lysate. Eur Respir J 2011; 38: Suppl. 55, 3023

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The maturation of dendritic cells mediated by a polyvalent mechanical bacterial lysate (PBML) results in the secretion of cytokines inducing an anti-bacterial polarization of the locoregional immune-response
Source: Eur Respir J 2004; 24: Suppl. 48, 357s
Year: 2004

The immuneresponse against bacterial antigens is generated in vivo by a mechanical bacterial lysate through a cross-talk between innate and adaptive immunity
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003

Lung resistance during cell mediated and antibody mediated lung hypersensitivity reaction induced with single antigen inhalation
Source: Eur Respir J 2001; 18: Suppl. 33, 103s
Year: 2001

Evaluation of serial interferon-gamma release assay testing in lung cancer patients treated with immune checkpoint inhibitors
Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis
Year: 2021


Exploring the molecular potential of bacterial lysates to reduce COVID-19 susceptibility of bronchial epithelial cells in vitro
Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies
Year: 2021


Epigenetic control of antiviral and innate immune response following viral infection in a lung epithelial model
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013


Microbial DNA and RNA induce a host defense reaction of human respiratory epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 207s
Year: 2002

Immunological responses after immunization of mice with DNA plasmid encoded ESAT6 antigen with polysaccharide matrix
Source: Eur Respir J 2006; 28: Suppl. 50, 342s
Year: 2006

Differential responses of monolayer and differentiated airway epithelial cell cultures to NTHi infection
Source: Annual Congress 2012 - Airway infections in children: from risk factors to treatment
Year: 2012


Oral presentation: Inhibition of innate host defense in airway epithelial cells by cigarette smoke in an in vitro infection model caused by suppression of NF-kB activation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Muramyldipeptide synergistically increases interleukin-8 secretion from bronchial epithelial cells in a cell culture model of gramnegative infection
Source: Eur Respir J 2006; 28: Suppl. 50, 340s
Year: 2006

Influence of tumour cell lysate on state of lymphocytes‘ activation after DCs stimulation in lung cancer
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008

Humoral immune changes induced by differentiated treatment in various stages of human tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 656s
Year: 2005

Humanized S.typhi flagellin (FliC) transfected non-small cell lung cancer (NSCLC) cells induce local inflammatory and necrotic changes in an experimental model
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011

Detection of thoracotomy-induced alterations in cell- and humoral mediated immune response
Source: Eur Respir J 2003; 22: Suppl. 45, 368s
Year: 2003

EPs®7630 reduced Rhinovirus bronchial epithelial cell infection and modified host defence systems
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018

Infectious Human Rhinovirus persists in in vitro human nasal epithelial cells with waning induction of corresponding innate immune signatures activation
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019

Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003